| Pharmaceutical active ingredients: |
| EnalaprilHydrochlorothiazide |
| Available forms, composition and doses of Co-Reniten: |
| Tablets; Oral; Enalapril Maleate 20 mg; Hydrochlorothiazide 12.5 mg |
| Co-Reniten medical category: |
| Human:ACE inhibitorsAngiotensin-Converting Enzyme inhibitorsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09BA02 - Enalapril and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |